enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.580
-0.050 (-3.07%)
At close: Oct 22, 2026, 4:00 PM EDT
1.583
+0.003 (0.19%)
After-hours: Oct 22, 2026, 7:30 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $105.89 million as of October 22, 2026. It is the 24,718th most valuable company in the world and the 4,043rd biggest in the United States. Its market cap has decreased by 75.67% in one year.
Market Cap
105.89M
Enterprise Value
-127.16M
1-Year Change
-75.67%
Global Rank
Country Rank
#4,043 United States
Category
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $105.89M, a decrease of -32.09%. That is a compound annual growth rate of -7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 105.89M | -82.49% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 114.89M |
| NRx Pharmaceuticals | 114.65M |
| Seer, Inc. | 114.07M |
| TuHURA Biosciences | 113.43M |
| Kazia Therapeutics | 113.18M |
| Genelux | 109.79M |
| Unicycive Therapeutics | 109.47M |
| Humacyte | 109.26M |